Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Divestments (2018 - 2024)

Avanos Medical (AVNS) has disclosed Divestments for 3 consecutive years, with -$2.1 million as the latest value for Q4 2024.

  • Quarterly Divestments fell 102.36% to -$2.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Sep 2025, down 102.31% year-over-year, with the annual reading at $89.0 million for FY2023, N/A changed from the prior year.
  • Divestments hit -$2.1 million in Q4 2024 for Avanos Medical, down from $2.1 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $89.0 million in Q4 2023 to a low of -$2.1 million in Q4 2024.